Prevalence of hepatitis C virus antibodies in hemodialysis patients in the area of Milan.
We studied the seroprevalence of antibodies to hepatitis C virus (HCV Ab) in a cohort of 229 chronic hemodialysis patients followed by 6 Dialysis Units in the Milan area. HCV Ab was present in 51 (22.3%) of 229 examined patients. Previous blood transfusions and surgery did not clearly influence HCV seroconversion, whereas duration of dialysis treatment seems to be strictly related to HCV Ab positivity.
Gubertini
G
G
Second Department of Infectious Diseases, L. Sacco Hospital, Milan, Italy.
Scorza
D
D
Beccari
M
M
Buccianti
G
G
Costantino
A
A
Spotti
D
D
Graziani
G
G
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015331:Cohort Studies; D003428:Cross Infection / Q000453:epidemiology / Q000276:immunology / Q000635:transmission; D016174:Hepacivirus / Q000276:immunology*; D006508:Hepatitis Antibodies / Q000097:blood*; D006526:Hepatitis C / Q000453:epidemiology / Q000276:immunology / Q000635:transmission; D006801:Humans; D007558:Italy / Q000453:epidemiology; D008875:Middle Aged; D006435:Renal Dialysis / Q000009:adverse effects*
D006508:Hepatitis Antibodies